Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ossur Hf : Share buy-back of 1,478,700 own shares

Ossur Hf
Posted on: 13 Mar 18

Announcement no. 21/2018
Reykjavik, 13 March 2018 

Share buy-back of 1,478,700 own shares

Today, Össur purchased 1,478,700 own shares at the price of DKK 28.10 per share. The total purchase price amounted to DKK 41.55 million, which corresponds to approx. USD 6.9 million.  

The purpose of the share buy-back is to adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy.

Further information

David Hreidarsson
Investor Relations
+354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide. .


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ossur Hf via GlobeNewswire

Last updated on: 14/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.